| Synonym | Cell Type | QPCR Expression | Normalized To | Data From |
|---|
| Dtx3L | DN1 | -4.15 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN1 | -3.7 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN1 | -4 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | DN2 | -3.1 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN2 | -3.92 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN2 | -4 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | DN3a | -2.92 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN3a | -3 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN3a | -3.51 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | DN3b | -2.89 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN3b | -4.7 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN3b | -4 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | DN4 | -4.7 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN4 | -4.77 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | DN4 | -4.12 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | LSK- | -4.48 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK- | -4.7 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK- | -4.23 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK- | -5.15 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK- | -3.88 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK- | -5.15 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | LSK+ | -5.15 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK+ | -3.89 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK+ | -5.15 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK+ | -4.48 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK+ | -4.7 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | LSK+ | -4.23 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | PreM | -3.6 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | PreM | -4.27 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | PreM | -4.96 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | PreM | -3.6 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | PreM | -4.27 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | PreM | -4.97 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | ProB | -3.64 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProB | -4.05 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProB | -4.19 | GAPD | LSK vs DN Stages (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProB | -3.63 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProB | -4.05 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProB | -4.19 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| . | | | | |
| Dtx3L | ProT | -2.93 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProT | -2.98 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
| Dtx3L | ProT | -3.5 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |